Engineering NK Cells to Deliver Customized "Off-the-Shelf" Cancer Therapies at Scale 

Wei Li, PhD
Chief Scientific Officer

download.png

April 1st, 2022

 
Precision Stem Cell Engineering to Unlock the Power of NK Cells
Flex-NK™ Cell Engager Antibodies to Activate NK Cells At the Tumor Site 
Differentiated Pipeline, With Multiple First-In-Class Therapeutic Candidates